|
Volumn 64, Issue 4, 2011, Pages 235-236
|
EMA revokes marketing authorization for bufexamac
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUFEXAMAC;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG SURVEILLANCE PROGRAM;
DRUG UTILIZATION;
ERYTHEMA MULTIFORME;
HUMAN;
LETTER;
MEDICAL SOCIETY;
SKIN ALLERGY;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BUFEXAMAC;
DECISION MAKING, ORGANIZATIONAL;
EUROPE;
EUROPEAN UNION;
GOVERNMENT AGENCIES;
HUMANS;
MARKETING;
SAFETY-BASED DRUG WITHDRAWALS;
|
EID: 79952589722
PISSN: 01051873
EISSN: 16000536
Source Type: Journal
DOI: 10.1111/j.1600-0536.2011.01883.x Document Type: Letter |
Times cited : (17)
|
References (4)
|